Fri, Jul 26, 9:16 PM (43 days ago)
Autonomix Medical, Inc. filed an amendment (10-K/A) to its Annual Report for the fiscal year ended March 31, 2024. This amendment includes previously omitted information required by Items 10 through 14 of Part III of Form 10-K, covering directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and accounting fees. It does not include or alter financial statements. Key points: 1. **Directors and Executive Officers**: Includes new CEO Brad Hauser and details on other executives and board members. 2. **Executive Compensation**: Lists salaries and bonuses, with new employment agreements for Hauser ($450K salary) and Bisson ($150K salary post-June 2024). 3. **Equity Awards**: Details stock options granted to executives. 4. **Related Transactions**: Discloses transactions with entities tied to executives and directors. 5. **Accounting Fees**: Audit fees totaled $221,550 for FY 2024. The amendment aims to comply with SEC requirements and includes new certifications by the principal executive and financial officers.